Annual report [Section 13 and 15(d), not S-K Item 405]

Segments (Tables)

v3.25.1
Segments (Tables)
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Schedule of Research and Development Expenses The following table summarizes our research and development expenses for the years ended December 31, 2024 and 2023:
 
  Year Ended December 31,
  2024 2023
  (in thousands)
Nonclinical expenses $ 570  $ 1,029 
Clinical expenses 9,966  5,780 
CMC expenses 5,106  1,855 
Internal expenses:
Salaries, benefits and related costs 6,164  3,576 
Stock-based compensation expense 2,402  1,318 
Other 229  226 
  $ 24,437  $ 13,784